Strongyloides stercoralis: The Most Prevalent Parasitic Cause of Eosinophilia in Gilan Province, Northern Iran
,
Abstract
Background: Eosinophilia occurs in a wide variety of situations such as parasitic infections, allergic disorders, and malignancies. Most cases of eosinophilia of parasitic origin, especially those with a tissue migration life cycles consists of human infections by helminth parasites. The aim of present study was to determine the parasitic causes of eosinophilia in patients in a major endemic area of human fascioliasis in Gilan Province, northern part of Iran.
Methods: One hundred and fifty patients presenting with an elevated eosinophilia attending infectious disease clinics with or without clinical symptoms, were examined. After clinical history evaluation and physical examination, coprological examinations were performed using the formalin-ether and the Kato-Katz techniques for detection of Fasciola sp. and intestinal parasites.
Results: Forty two percent of patients were infected with S. stercoralis, nine (6%) were found to be infected with Fasciola sp. while only a single patient (0.7%) were infected by Ttrichostrongylus sp.
Conclusion: Local clinicians in Gilan may consider eosinophilia as a suggestive indication for diagnosis of human fascioliasis, especially when microscopic stool and/or serological tests are negative. Based on the results, local physicians should consider S. stercoralis as the potential causes of eosinophilia in patients with elevated eosinophilia.
Thomas B, Nutman MD. Evaluation and differential diagnosis of marked, persistent eosinophilia. Immunol Allergy Clin North Am. 2007; 27(3):529-549.
Raja SV, David SC, Guha K. Intestinal strongyloidiasis and hyperinfection syndrome. Clin Mol Allergy. 2006; 4:8.
Paiboon S. Tuanchai S, Smarn T, Weerayutt D, Jiraporn S, Yasunori F, Katsuhiko A. Epidemiology of Strongyloides stercoralis in north-east Thailand: application of the agar plate culture technique compared with the enzyme-linked immunosorbent assay. Trans R Soc Trop Med Hyg. 2003; 97:398-402.
Grove DI. Human strongyloidiasis. Adv Parasit. 1996; 38:251-309.
Suvajdzic N, Kranjcic-Zec I, Jovanovic V, Popovic D, Colovic M. Fatal strongyloidiasis following corticosteroid therapy in a patient with chronic idiopathic thrombocytopenia. Haematologia. 1999; 29:323-326.
Yee A, Boylen CT, Noguchi T, Klatt EC, Sharma OP. Fatal Strongyloides stercoralis infection in a patient receiving corticosteroids. West J Med. 1999; 146:363-364.
Siddiqui AA, Berk SL, Genta RM. Strongiloidiasis in tropical infections diseases. Philadelphia: Elsevier. 2005 1274-1285.
Nucci M, Portugal R, Pulcheri W, Spector N, Ferreira SB, de Castro MB, Noe R, de Oliveira HP. Strongyloidiasis in patients with hematologic malignancies. Clin Infect Dis. 1995; 21:675-677.
Feitosa G, Bandeira AC, Sampaio DP, Badaro R, Brites C. High prevalence of giardiasis and strongyloidiasis among HIV-infected patients in Bahia, Brazil. Braz J Infec Dis.2001; 5:339-344.
Dixon AC, Yanagihara ET, Kwock DW, Nakamura JM. Strongyloidiasis associated with human T-cell lymphotropic virus type I infection in a non-endemic area. West J Med. 1989; 151:410-413.
Gutuzzo E, Terashima A, Alvarez H, Tello R, Infante R, Watts DM, Freedman DO. Strongyloides stercoralis hyperinfection associated with human T cell lymphotropic virus type-I infection in Peru. Am J Trop Med Hyg. 1999; 60:146-149.
Sauca SG, Barrufet BP, Besa BA, Rodrigues RE. Strongyloides stercoralis hyperinfection in a patient with acquired immunodeficiency syndrome. An Med Interna. 2005; 22:139-141.
Richter J, Schwartz U, Ellerbrok H, Poggensee G, Pauli G. Recurrent strongyloidiasis as an indicator of HTLV-I infection. Dtsch Med Wochenschr. 2005; 130:1007-1010.
Viney ME. The biology and genomics of Strongyloides. Med Microbiol Immunol. 2006; 195:49-54.
de Kaminsky RG. Evaluation of three methods for laboratory diagnosis of Strongyloides stercoralis infection. J Parasitol. 1993; 79:277-280.
Sukhavat K, Morakote N, Chaiwong P, Piangjai S. Comparative efficacy of four methods for the detection of Strongyloides stercoralis in human stool specimens. Ann Trop Med Parasitol. 1994; 88: 95-96.
Sato Y, Kobayashi J, Toma H, Shiroma Y. Efficacy of stool examination for detection of Strongyloides stercoralis infection. Am J Trop Med Hyg. 1995; 53:248-250.
Kia EB, Mahmoudi M, Zahabiun F, Meamar AR. An evaluation on the efficacy of agar plate culture for detection of Strongyloides stercoralis. Iranian J Parasitol. 2007; 2(1):29-34.
Arakaki T, Iwanaga M, Kinjo F, Saito A, Asato R, Ikeshiro T. Efficacy of Agarplate culture in detection of Strongyloidse stercoralis infection. J Parasitol. 1990; 76:425-428.
Gam AA, Neva FA and Krotoski WA. Comparative sensitivity and specificity of ELISA and IHA for serodiagnosis of strongyloidiasis with larval antigens. Am J Trop Med Hyg. 1987; 37:157-161.
S Koosha, M Fesharaki, MB Rokni. Comparison of enzyme-linked immunosorbent assay and indirect immunofluorescence assay in the diagnosis of human strongyloidiasis. Indian J Gastroenterol. 2004;23:214-216.
Uparanukraw P, Phongsri S, Morakote N. Fluctuations of larval excretion in Strongyloides stercoralis infection. Am J Trop Med Hyg. 1999; 66:967-973.
Siddiqui AA, Berk SL. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis. 2001; 33:1040–47.
Gill GV, Welch E, Bailey JW, Bell DR, Beeching NJ. Chronic Strongyloides stercoralis infection in former British Far East prisoners of war. Q J Med. 2004; 97:789-795.
Román-Sánchez P, Pastor-Guzmán A, Moreno-Guillén S, Igual-Adell R, Suner- Generoso S, Toenero-Estébanez C. High prevalence of Strongyloides stercoralis among farm workers on the Mediterranean coast of Spain: analysis of the predictive factors of infection in developed countries. Am J Trop Med Hyg. 2003; 63(3):336-340.
Schutle C, Krebs B, Jelinek T, Nothdurft HD, Von SF, Loscher T. Diagnostic significance of blood eosinophlia in returning travelers. Clin Infect Dis. 2002; 34:407-411.
Rokni MB. The present status of human helminthic diseases in Iran. Ann Trop Med Parasitol. 2008; 102(4):283-295.
Ashrafi K, Valero MA, Forghan-Parast K, Rezaeian M, Shahtaheri SJ, Hadiani MR, Bargues MD, Mas-Coma S. Potential transmission of human fascioliasis through traditional local foods in northern Iran. Iranian J Pub Health. 2006; 35(2); 57-63.
Ashrafi K, Massoud J, Holakuei Naieni K, Mahmoodi M, Jo-Afshani MA, Valero MA, Fuentes MV, Khoubbane M, Artigas P. Bargues MD and Mas-Coma S. Evidence suggesting that Fasciola gigantica may be the most prevalent causal agent of fascioliasis in the endemic province of Gilan, northern Iran. Iranian J Pub Health. 2004; 33 (4):31-37.
Massoud J. Fascioliasis outbreak of man and drug test (Triclabendazole) in Caspian Sea Littoral, northern part of Iran. Bulletin de la Societe Française de Parasitologie. 1990; 8: 438.
Kathleen R. Page, Zenilman J. Eosinophilia in a patient from South America. JAMA. 2008; 299(4):437-444.
Notman TB. Evaluation and differential diagnosis of marked, persistent eosinophilia. Immunol Allergy Clin North Am. 2007; 27(3):529-549.
Loutfy MR, Wilson M, Keystone JS, Kain KC. Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area. Am J Trop Med Hyg. 2002; 66(6):749-752.
Gill GV, Bailey JW. Eosinophilia as a marker for chronic strongyloidiasis- use of a serum ELISA test to detect asymptomatic cases. Ann Trop Med Parasitol. 1989; 83(3):249-52.’
Ashrafi K, Valero MA, Massoud J, Sobhani A, Solaymani-Mohammadi S, Conde P, Khoubbane M, Bargues MD, Mas-Coma S. Plant-borne human contamination by fascioliasis. Am J Trop Med Hyg. 2006; 75(2):295-302.
Mas-Coma S. Epidemiology of fascioliasis in human endemic areas. J Helminthol. 2005; 79 (3): 207-216.
| Files | ||
| Issue | Vol 5 No 3 (2010) | |
| Section | Articles | |
| Keywords | ||
| Strongyloides stercoralis Strongyloidiasis Eosinophilia Iran | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
